HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) closed its last session at $5.13. The stock traded within a range of $4.20 and $5.49. The company operates in the Healthcare sector with a market capitalization of 70130. Trading volume for HTG Molecular Diagnostics, Inc. was 9.04 Million in its previous trading session. Currently, HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) has an average volume of 1.39 Million.
HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona.
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) received a Buy rating from 1 analysts. 0 analysts gave its stock an Outperform rating. 0 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) touched its 1-Year High price of $13.25 on 03/24/17 and its 1-Year Low price of $ 1.20 on 02/24/17.
EPS & Financials
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) reported its EPS in the last quarter as $-0.46/Share beating the analyst estimate of $-0.52/Share by a difference of $0.06. This showed a surprise of 11.5% in the last quarter earnings.
For the current quarter, 2 analysts are projecting a mean EPS of $-0.31/share. According to their observations and findings, the stock could provide a high EPS of $-0.23/share and a low EPS of $-0.38/share.
Analysts believe that the company has the potential to earn average revenue of $6.98 Million for the current quarter. According to their predictions high & low revenue estimates are 7.05 Million and 6.9 Million respectively.
By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) has a 20-Day average volume of 2.67 Million. According to today’s trading volume HTG Molecular Diagnostics, Inc. is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.
Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BULLISH trend as well.
The company currently has an insider ownership of 4 Percent and Institutional ownership of 17.2 Percent. The return on assets stands at -136.2%, Return on Equity currently is 401.6% and the Return on Investment value is -164.5%.
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gross margin percentage stands at 41.6% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 39.61% with a 50-Day Simple Moving Average of 78.06 percent. As of today, the company has a SMA200 (200-day simple moving average) of 94.23 Percent. The Stock has YTD (year to date) performance of 152.71 percent.
The TTM operating margin for the company stands at 0%. The return on invested capital is at -164.5%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.
The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 94.23%, and has a solid year to date (YTD) performance of 152.71% which means that the stock is constantly adding to its value from the previous fiscal year end price.